First of all, Ship2 is a negative modulator of receptor endocytosis [26] and its association through Sam–Sam interaction with EphA2 is likely connected to pro-cancer effects in cancer cells, as it also favors EphA2 ligand-independent pro-migratory roles [21]. Here, INPPL1 is linked to cancer.